Department of Renal Medicine, Royal Derby Hospital, Derby, UK.
University of Lyon, Lyon, France.
Hemodial Int. 2020 Oct;24(4):506-515. doi: 10.1111/hdi.12863. Epub 2020 Aug 25.
Hemodialysis (HD) induces myocardial stunning and is associated with adverse cardiovascular outcomes. Intradialytic hypotension is a modifiable determinant of myocardial stunning. Magnesium (Mg) is reported to be valuable in maintaining intradialytic blood pressure, which potentially would protect against demand myocardial ischemia. This study aimed to compare high vs. low dialysate Mg effects on intradialytic hemodynamics and HD-induced myocardial stunning.
Twenty stable prevalent HD patients entered a randomized cross-over trial of low (0.5 mmol/L) vs. high (1.0 mmol/L) dialysate Mg. Patients were studied after 2 weeks of standard HD with each Mg concentration. Serial echocardiography assessed myocardial stunning, measured by left ventricular regional wall motion abnormalities (RWMAs). Continuous intradialytic hemodynamics were measured noninvasively using thoracic bioimpedance.
Median predialysis serum Mg was higher with high dialysate Mg (1.45[1.29-1.55] vs. 1.03[0.98-1.1] mmol/L, P < 0.0001). There was no significant difference in maximum intradialytic reduction in systolic BP. There was no significant difference in stroke volume, total peripheral resistance, and cardiac output. Overall ventricular global longitudinal strain (GLS) (as a sensitive marker of contractile function) was higher before dialysis in high Mg group, but there was no difference in GLS at peak stress. However, we showed a significant correlation between Mg changes and GLS changes, r = -0.47, P = 0.02. There was no difference in mean number of peak stress RWMAs per patient (4.0 ± 2.2 vs. 4.3 ± 2.9, P = 0.5). Ultrafiltration volume, a critical determinant of stunning, was not different between high and low dialysate Mg studies (1.35[0-3.3] vs. 1.5[0-2.8], P = 0.49).
Manipulation of magnesium by altering dialysate magnesium concentration does not influence intradialytic hemodynamic response or HD-induced myocardial stunning in the short term. However, decreasing Mg changes appears to decrease GLS changes.
血液透析(HD)可导致心肌顿抑,并与不良心血管结局相关。透析中低血压是心肌顿抑的可调节决定因素。有报道称,镁(Mg)在维持透析中血压方面具有重要作用,这可能有助于防止需求性心肌缺血。本研究旨在比较高和低透析液 Mg 对透析中血液动力学和 HD 诱导的心肌顿抑的影响。
20 例稳定的常规 HD 患者参与了一项随机交叉试验,比较低(0.5mmol/L)和高(1.0mmol/L)透析液 Mg 的作用。患者在接受 2 周标准 HD 后分别接受两种 Mg 浓度的治疗。连续超声心动图评估左心室节段壁运动异常(RWMAs)评估心肌顿抑。使用胸部生物阻抗无创测量连续透析中的血液动力学。
高透析液 Mg 组患者的中位预透析血清 Mg 更高(1.45[1.29-1.55] vs. 1.03[0.98-1.1]mmol/L,P<0.0001)。最大透析中收缩压的降低无显著差异。心输出量、总外周阻力和每搏量无显著差异。整体心室纵向应变(GLS)(作为收缩功能的敏感标志物)在高 Mg 组患者透析前更高,但在峰值应激时无差异。然而,我们显示了 Mg 变化与 GLS 变化之间存在显著相关性,r=-0.47,P=0.02。每位患者的峰值应激 RWMAs 平均值无差异(4.0±2.2 vs. 4.3±2.9,P=0.5)。超滤量(影响顿抑的关键决定因素)在高和低透析液 Mg 研究之间无差异(1.35[0-3.3] vs. 1.5[0-2.8],P=0.49)。
通过改变透析液镁浓度来调节镁,在短期内不会影响透析中的血液动力学反应或 HD 诱导的心肌顿抑。然而,Mg 变化的减少似乎会减少 GLS 变化。